uclahealth.org/clinical-tri...
For people previously treated with apalutamide, darolutamide, enzalutamide, abiraterone
It’s and ADC targeting B7-H3 checkpoint
clinicaltrials.gov/study/NC...
Targets PD1
phase 2 study for mCRPC: uclahealth.org... - Advanced Prostate...
phase 2 study for mCRPC
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of Lutetium- 177,...
Good news for mCRPC (hopefully), phase 2
such as apalutamide, darolutamide, abiraterone and enzalutamide are included in the study.\\"...
BRCA/ATM mutations mCRPC: good news from the TALAPRO 2 study
When I read median pfs not reached I feel good!...
Related Posts
- Small Cell Neuroendocrine PC - Phase 2 study
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve mCRPC: a randomized, controlled, phase 2 non inferiority trial.
AMG 212 Phase 1 study shows potential.
ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule
ARV-110 clear phase 1 for mCRPC very promising.
